Why you should make South Korea a deal making target
Over the past couple of years, we have seen huge growth in the pharma and biotech industries in Asia, and especially in Korea. Historically, the Korean pharmaceutical industry was built on manufacturing and generics capabilities, however, in the past few decades many more innovative technologies and products have emerged. Viewed as the next semi-conductor industry, and therefore a significant boost to the economy and a generator of large numbers of high value jobs, higher numbers of Korean companies and investors have become very active in new drug and technology development – with significant support from the Korean government.
Join Adrian Dawkes and Summer Park of PharmaVentures as they discuss this emerging market and how you can explore the new business opportunities that Korea has to offer.